Dose—Response Studies of Lormetazepam: Efficacy, Side Effects, and Rebound Insomnia
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Lormetazepam, an investigational hypnotic, was evaluated for efficacy and withdrawal phenomena in doses of 0.5, 1.0, 1.5, and 2.0 mg in four separate sleep laboratory protocols, each including four placebo baseline nights, seven drug nights, and three placebo withdrawal nights. A moderate degree of efficacy was shown across the four doses, but this was quite variable. There was no dose—response effect for efficacy for either the first three or last three nights of this short‐term administration period. In general, there was less efficacy on the later drug nights, indicating a potential for the development of tolerance over a relatively short period of time. Following drug withdrawal, there was a dose‐related worsening of sleep above baseline levels (rebound insomnia). The peak degree of worsening of sleep following drug withdrawal was more than two times greater than the peak degree of improvement of sleep with drug administration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE FIRST NIGHT EFFECT: AN EEG STUDYOF SLEEP
Agnew, H. W., Webb, W. B., & Williams, R. L. (1966) · Psychophysiology · doi:10.1111/j.1469-8986.1966.tb02650.x · Cited by 1,147
Rebound Insomnia: A New Clinical Syndrome
Kales, A., Scharf, M. B., & Kales, J. D. (1978) · Science · doi:10.1126/science.684426 · Cited by 200
Self-citationRebound Insomnia and Rebound Anxiety: A Review
Kales, A., Soldatos, C. R., Bixler, E. O., & Kales, J. D. (2008) · Pharmacology · doi:10.1159/000137794 · Cited by 198
Self-citationNitrazepam: lastingly effective but trouble on withdrawal.
Adam, K., Adamson, L., Brezinova, V, & Hunter, W. M. (1976) · BMJ · doi:10.1136/bmj.1.6025.1558 · Cited by 90
HYPNOTIC EFFICACY OF TEMAZEPAM: A LONG‐TERM SLEEP LABORATORY EVALUATION
MITLER, M. M., CARSKADON, M. A., PHILLIPS, R. L., STERLING, W. R., ZARCONE, V. P., SPIEGEL, R., GUILLEMINAULT, C., & DEMENT, W. C. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb00459.x · Cited by 60
Intermediate Use of Triazolam: A Sleep Laboratory Study
Roth, T., Kramer, M., & Lutz, T. (1976) · Journal of International Medical Research · doi:10.1177/030006057600400109 · Cited by 60
Cited by
Effect of Gradual Withdrawal on the Rebound Sleep Disorder after Discontinuation of Triazolam
Greenblatt, D. J., Harmatz, J. S., Zinny, M. A., & Shader, R. I. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709173171202 · Cited by 96
Long‐term benzodiazepine treatment: Is it ever justified?
Chen, Y., & Lader, M. (1990) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.470050403 · Cited by 9
Metadata
- Authors
- KALES, A., BIXLER, E. O., SOLDATOS, C. R., MITSKY, D. J., & KALES, J. D.
- Venue
- The Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1982-11-12
- Volume
- 22
- Issue
- 11
- Pages
- 520-530
- ISSN
- 0021-9754 (ISSN-L)
- 0091-2700
- 1552-4604
- OpenAlex
- W1999589177
- Cited by
- 40
- References
- 6
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dose—Response Studies of Lormetazepam: Efficacy, Side Effects, and Rebound Insomnia. https://app.cochat.ai/papers/10.1002/j.1552-4604.1982.tb02645.x
- The paper
- KALES, A., BIXLER, E. O., SOLDATOS, C. R., MITSKY, D. J., & KALES, J. D. (1982). Dose—Response Studies of Lormetazepam: Efficacy, Side Effects, and Rebound Insomnia. The Journal of Clinical Pharmacology. https://doi.org/10.1002/j.1552-4604.1982.tb02645.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.